Public Comments
Comments provided on: January 18, 2019
Comments provided to: European Data Protection Board
Resource Type: Public Comments
Regulation of New Drugs and Clinical Trials Rules: Comments and Recommendations
Public Comments
Comments provided on: March 16, 2018
Comments provided to: Ministry of Health and Family Welfare, New Delhi, India
NIH and FDA Draft Clinical Trial Protocol Template for Phase 2 and 3 IND/IDE Studies
Public Comments
Comments Provided on: April 15, 2016
Comments Provided to: The International Committee of Medical Journal Editors
Scientific Data – Editorial Comments
Public Comments
Comments provided on: September 7, 2015
Comments provided to: Scientific Data
Comments provided by: MRCT Center Data Sharing and Transparency workgroup
Comments to China FDA on resolving the backlog
Public Comments
Comments provided on: August 11, 2015
Comments: China Food and Drug Administration, Beijing, China
Comments to China FDA on resolving the backlog, Chinese Translation
Public Comments
Comments provided on: August 11, 2015
Comments provided to: China Food and Drug Administration, Beijing, China
Drugs and Cosmetics Amendment Bill Comments and Recommendations
Public Comments
Comments provided on: January 11, 2015
Comments provided to: Department of Health and Family Welfare, New Delhi, India
Comments to Draft Rules to Amend the Drugs and Cosmetics Rules
Public Comments
Comments provided on: June 18, 2014
Comments provided to: Ministry of Health and Family Welfare, Government of India
Comments on Declaration of Helsinki
Public Comments
Comments provided on: November 19, 2020
Comments provided to: World Medical Association, France